Suppr超能文献

糖尿病在肝硬化进展为肝细胞癌中的潜在作用:来自中国 HBV 感染患者的一项横断面病例对照研究。

Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection.

机构信息

Department of Gastroenterology, China-Japan Friendship Hospital, Ministry of Health, Beijing 100029, China.

出版信息

Hepatobiliary Pancreat Dis Int. 2013 Aug;12(4):385-93. doi: 10.1016/s1499-3872(13)60060-0.

Abstract

BACKGROUND

Diabetes mellitus (DM) is regarded as a new risk factor for hepatocellular carcinoma (HCC), but few studies have focused on the potential role of DM in the progression of cirrhosis to HCC as well as in patients with simple HBV infection.

METHODS

A cohort of 1028 patients, treated at our hospital and with a hospital discharge diagnosis of HCC and/or cirrhosis, was screened. Among them, 558 were diagnosed with chronic HBV infection and 370 were analyzed statistically according to the diagnostic, inclusion and exclusion criteria. The demographic, clinical, metabolic, virological, biochemical, radiological and pathological features were analyzed and the multivariate logistic regression model was used to determine the potential role of DM.

RESULTS

In 248 cirrhotic patients, 76 were diabetic and their mean duration of DM was 4.6 years. In 122 HCC patients with cirrhosis, 25 were diabetic and their mean duration of DM was 4.4 years. Univariate analysis showed that compared with cirrhotic patients, the HCC patients had a higher percentage in males (P=0.001), a lower percentage in DM patients (P=0.039), a higher percentage in cigarette smokers (P=0.005), a higher percentage in patients with AFP>400 ng/mL (P<0.001), higher values of white blood cells (P<0.001), hemoglobin (P<0.001) and platelet (P<0.001), increased levels of ALT (P<0.001) and GGT (P<0.001), higher total bilirubin (P=0.018) and albumin levels (P<0.001), and a lower international normalized ratio (P<0.001). Multivariate logistic regression analysis showed that DM was an independent associated factor for HCC [odds ratio (OR)=0.376; 95% CI, 0.175-0.807; P=0.012]. Even after the HCC patients were restricted to those with decompensated cirrhosis and compared with decompensated cirrhotic patients, the similar result was observed (OR=0.192; 95% CI, 0.054-0.679; P=0.010).

CONCLUSIONS

DM is an independent factor in the progression of cirrhosis to HCC, but the role may be contrary to our current viewpoint. To clarify the causal relationship of DM and HCC, prospective and experimental studies are required.

摘要

背景

糖尿病(DM)被认为是肝细胞癌(HCC)的一个新的危险因素,但很少有研究关注 DM 在肝硬化进展为 HCC 以及单纯乙型肝炎病毒(HBV)感染患者中的潜在作用。

方法

筛选了我院收治的 HCC 和/或肝硬化出院诊断的 1028 例患者。其中,558 例诊断为慢性 HBV 感染,根据诊断、纳入和排除标准进行了 370 例统计分析。分析了人口统计学、临床、代谢、病毒学、生化、影像学和病理学特征,并采用多变量 logistic 回归模型确定 DM 的潜在作用。

结果

在 248 例肝硬化患者中,76 例为糖尿病,DM 平均病程为 4.6 年。在 122 例肝硬化合并 HCC 的患者中,25 例为糖尿病,DM 平均病程为 4.4 年。单因素分析显示,与肝硬化患者相比,HCC 患者中男性比例更高(P=0.001),糖尿病患者比例更低(P=0.039),吸烟者比例更高(P=0.005),AFP>400ng/ml 的患者比例更高(P<0.001),白细胞(P<0.001)、血红蛋白(P<0.001)和血小板(P<0.001)值更高,ALT(P<0.001)和 GGT(P<0.001)水平更高,总胆红素(P=0.018)和白蛋白水平(P<0.001)更低,国际标准化比值(P<0.001)更低。多变量 logistic 回归分析显示,DM 是 HCC 的独立相关因素[比值比(OR)=0.376;95%可信区间,0.175-0.807;P=0.012]。即使将 HCC 患者限制在失代偿性肝硬化患者中,并与失代偿性肝硬化患者进行比较,也观察到了类似的结果(OR=0.192;95%可信区间,0.054-0.679;P=0.010)。

结论

DM 是肝硬化进展为 HCC 的一个独立因素,但作用可能与我们目前的观点相反。为了阐明 DM 和 HCC 之间的因果关系,需要进行前瞻性和实验性研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验